Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)

NCT00880243 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: GM-CSF

Sponsor

Acute Leukemia French Association

Collaborators

[object Object]